ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer
Oncotarget
◽
10.18632/oncotarget.13727
◽
2016
◽
Vol 8
(2)
◽
pp. 2320-2328
◽
Cited By ~ 33
Author(s):
Marzia A. Locatelli
◽
Philippe Aftimos
◽
E. Claire Dees
◽
Patricia M. LoRusso
◽
Mark D. Pegram
◽
...
Keyword(s):
Breast Cancer
◽
Phase I
◽
Triple Negative Breast Cancer
◽
Phase I Study
◽
Triple Negative
◽
Gamma Secretase
◽
Secretase Inhibitor
◽
Gamma Secretase Inhibitor
Download Full-text
Related Documents
Cited By
References
Phase I dose-finding study of the gamma secretase inhibitor PF-03084014 (PF-4014) in combination with docetaxel in patients (pts) with advanced triple-negative breast cancer (TNBC).
Journal of Clinical Oncology
◽
10.1200/jco.2015.33.15_suppl.1068
◽
2015
◽
Vol 33
(15_suppl)
◽
pp. 1068-1068
◽
Cited By ~ 1
Author(s):
Giuseppe Curigliano
◽
Philippe Georges Aftimos
◽
Elizabeth Claire Dees
◽
Patricia LoRusso
◽
Mark D. Pegram
◽
...
Keyword(s):
Breast Cancer
◽
Phase I
◽
Triple Negative Breast Cancer
◽
Triple Negative
◽
Dose Finding
◽
Gamma Secretase
◽
Secretase Inhibitor
◽
Finding Study
◽
Dose Finding Study
◽
Gamma Secretase Inhibitor
Download Full-text
DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer
Chemistry and Physics of Lipids
◽
10.1016/j.chemphyslip.2020.105033
◽
2021
◽
Vol 235
◽
pp. 105033
Author(s):
Sai Kiran S.S. Pindiprolu
◽
Praveen T. Krishnamurthy
◽
Chetan Dev
◽
Pavan Kumar Chintamaneni
Keyword(s):
Breast Cancer
◽
Triple Negative Breast Cancer
◽
Triple Negative
◽
Gamma Secretase
◽
Secretase Inhibitor
◽
Gamma Secretase Inhibitor
Download Full-text
Phenylboronic modified lipid nanocarriers mediated co-delivery of immunocytokine TRAIL and gamma-secretase inhibitor to triple negative breast cancer cells and cancer stem cells
Medical Hypotheses
◽
10.1016/j.mehy.2021.110716
◽
2021
◽
pp. 110716
Author(s):
Sai Kiran S.S. Pindiprolu
◽
Harani Avasarala
◽
SathisKumar Dinakaran
Keyword(s):
Breast Cancer
◽
Stem Cells
◽
Cancer Stem Cells
◽
Triple Negative Breast Cancer
◽
Breast Cancer Cells
◽
Triple Negative
◽
Gamma Secretase
◽
Secretase Inhibitor
◽
Lipid Nanocarriers
◽
Gamma Secretase Inhibitor
Download Full-text
Abstract P6-05-25: Ratio of notch receptors is critical for response to notch inhibition by a gamma-secretase inhibitor in triple negative breast cancer cells
10.1158/0008-5472.sabcs13-p6-05-25
◽
2013
◽
Author(s):
A Zlobin
◽
R Kuprys-Olsauskas
◽
D Shah
◽
C Osipo
Keyword(s):
Breast Cancer
◽
Cancer Cells
◽
Triple Negative Breast Cancer
◽
Breast Cancer Cells
◽
Triple Negative
◽
Gamma Secretase
◽
Notch Receptors
◽
Secretase Inhibitor
◽
Notch Inhibition
◽
Gamma Secretase Inhibitor
Download Full-text
Abstract 861: Analysis of predictive genes in triple negative breast cancer in response to a gamma-secretase inhibitor.
10.1158/1538-7445.am2013-861
◽
2013
◽
Author(s):
Roma Olsauskas-Kuprys
◽
Clodia Osipo
Keyword(s):
Breast Cancer
◽
Triple Negative Breast Cancer
◽
Triple Negative
◽
Gamma Secretase
◽
Secretase Inhibitor
◽
Gamma Secretase Inhibitor
Download Full-text
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer
Investigational New Drugs
◽
10.1007/s10637-020-00895-5
◽
2020
◽
Vol 38
(5)
◽
pp. 1400-1410
◽
Cited By ~ 1
Author(s):
Sagar Sardesai
◽
Mohamed Badawi
◽
Ewa Mrozek
◽
Evan Morgan
◽
Mitch Phelps
◽
...
Keyword(s):
Breast Cancer
◽
Phase I
◽
Triple Negative Breast Cancer
◽
Phase I Study
◽
Triple Negative
◽
Gamma Secretase
Download Full-text
Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation–Associated Breast Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-15-2137
◽
2016
◽
Vol 22
(12)
◽
pp. 2855-2864
◽
Cited By ~ 37
Author(s):
Eve T. Rodler
◽
Brenda F. Kurland
◽
Melissa Griffin
◽
Julie R. Gralow
◽
Peggy Porter
◽
...
Keyword(s):
Breast Cancer
◽
Phase I
◽
Triple Negative Breast Cancer
◽
Phase I Study
◽
Triple Negative
◽
Brca Mutation
Download Full-text
Abstract OT2-04-06: A phase I study of pembrolizumab combined with ruxolitinib in triple negative breast cancer (TNBC)
10.1158/1538-7445.sabcs19-ot2-04-06
◽
2020
◽
Author(s):
Daniel Almquist
Keyword(s):
Breast Cancer
◽
Phase I
◽
Triple Negative Breast Cancer
◽
Phase I Study
◽
Triple Negative
Download Full-text
A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Patients With Triple Negative Breast Cancer and an Incomplete Pathologic Response
Case Medical Research
◽
10.31525/ct1-nct03945721
◽
2019
◽
Author(s):
Keyword(s):
Breast Cancer
◽
Phase I
◽
Triple Negative Breast Cancer
◽
Phase I Study
◽
Triple Negative
◽
Pathologic Response
Download Full-text
A phase I study of JS001, a humanized PD-1mAbin patients with advanced triple negative breast cancer.
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.e15093
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. e15093-e15093
◽
Cited By ~ 1
Author(s):
Li Bian
◽
Huiqiang Zhang
◽
Tao Wang
◽
Shaohua Zhang
◽
Jianbin Li
◽
...
Keyword(s):
Breast Cancer
◽
Phase I
◽
Triple Negative Breast Cancer
◽
Phase I Study
◽
Triple Negative
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close